166 related articles for article (PubMed ID: 37886071)
1. Exploring cell cycle-mediated regulations of glycolysis in budding yeast.
Zhang Y; Barberis M
Front Microbiol; 2023; 14():1270487. PubMed ID: 37886071
[TBL] [Abstract][Full Text] [Related]
2. Distinct activities of the related protein kinases Cdk1 and Ime2.
Sawarynski KE; Kaplun A; Tzivion G; Brush GS
Biochim Biophys Acta; 2007 Mar; 1773(3):450-6. PubMed ID: 17137646
[TBL] [Abstract][Full Text] [Related]
3. Double-negative feedback between S-phase cyclin-CDK and CKI generates abruptness in the G1/S switch.
Venta R; Valk E; Kõivomägi M; Loog M
Front Physiol; 2012; 3():459. PubMed ID: 23230424
[TBL] [Abstract][Full Text] [Related]
4. Identification of YPL014W (Cip1) as a novel negative regulator of cyclin-dependent kinase in Saccharomyces cerevisiae.
Ren P; Malik A; Zeng F
Genes Cells; 2016 Jun; 21(6):543-52. PubMed ID: 27005485
[TBL] [Abstract][Full Text] [Related]
5. Sic1 as a timer of Clb cyclin waves in the yeast cell cycle--design principle of not just an inhibitor.
Barberis M
FEBS J; 2012 Sep; 279(18):3386-410. PubMed ID: 22356687
[TBL] [Abstract][Full Text] [Related]
6. Unraveling interactions of cell cycle-regulating proteins Sic1 and B-type cyclins in living yeast cells: a FLIM-FRET approach.
Schreiber G; Barberis M; Scolari S; Klaus C; Herrmann A; Klipp E
FASEB J; 2012 Feb; 26(2):546-54. PubMed ID: 22002907
[TBL] [Abstract][Full Text] [Related]
7. The yeast cyclin-dependent kinase inhibitor Sic1 and mammalian p27Kip1 are functional homologues with a structurally conserved inhibitory domain.
Barberis M; De Gioia L; Ruzzene M; Sarno S; Coccetti P; Fantucci P; Vanoni M; Alberghina L
Biochem J; 2005 May; 387(Pt 3):639-47. PubMed ID: 15649124
[TBL] [Abstract][Full Text] [Related]
8. Multisite phosphorylation by Cdk1 initiates delayed negative feedback to control mitotic transcription.
Asfaha JB; Örd M; Carlson CR; Faustova I; Loog M; Morgan DO
Curr Biol; 2022 Jan; 32(1):256-263.e4. PubMed ID: 34818519
[TBL] [Abstract][Full Text] [Related]
9. The Mck1 GSK-3 kinase inhibits the activity of Clb2-Cdk1 post-nuclear division.
McQueen J; van Dyk D; Young B; Loewen C; Measday V
Cell Cycle; 2012 Sep; 11(18):3421-32. PubMed ID: 22918234
[TBL] [Abstract][Full Text] [Related]
10. Yeast IME2 functions early in meiosis upstream of cell cycle-regulated SBF and MBF targets.
Brush GS; Najor NA; Dombkowski AA; Cukovic D; Sawarynski KE
PLoS One; 2012; 7(2):e31575. PubMed ID: 22393365
[TBL] [Abstract][Full Text] [Related]
11. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
Kõivomägi M
Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
[TBL] [Abstract][Full Text] [Related]
12. Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates.
Loog M; Morgan DO
Nature; 2005 Mar; 434(7029):104-8. PubMed ID: 15744308
[TBL] [Abstract][Full Text] [Related]
13. Cell Cycle-Dependent Transcription: The Cyclin Dependent Kinase Cdk1 Is a Direct Regulator of Basal Transcription Machineries.
Enserink JM; Chymkowitch P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163213
[TBL] [Abstract][Full Text] [Related]
14. TORC1 coordinates the conversion of Sic1 from a target to an inhibitor of cyclin-CDK-Cks1.
Moreno-Torres M; Jaquenoud M; Péli-Gulli MP; Nicastro R; De Virgilio C
Cell Discov; 2017; 3():17012. PubMed ID: 28496991
[TBL] [Abstract][Full Text] [Related]
15. Cdc6 cooperates with Sic1 and Hct1 to inactivate mitotic cyclin-dependent kinases.
Calzada A; Sacristán M; Sánchez E; Bueno A
Nature; 2001 Jul; 412(6844):355-8. PubMed ID: 11460169
[TBL] [Abstract][Full Text] [Related]
16. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
[TBL] [Abstract][Full Text] [Related]
17. Rux is a cyclin-dependent kinase inhibitor (CKI) specific for mitotic cyclin-Cdk complexes.
Foley E; O'Farrell PH; Sprenger F
Curr Biol; 1999 Dec; 9(23):1392-402. PubMed ID: 10607563
[TBL] [Abstract][Full Text] [Related]
18. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
20. Targets of the cyclin-dependent kinase Cdk1.
Ubersax JA; Woodbury EL; Quang PN; Paraz M; Blethrow JD; Shah K; Shokat KM; Morgan DO
Nature; 2003 Oct; 425(6960):859-64. PubMed ID: 14574415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
